Oxaliplatin and irinotecan chemotherapy in advanced gastric cancer.: Final results of a multicenter phase II trial.

被引：0
作者：
Woell, E.
Kuehr, T.
Eisterer, W.
Gattringer, K.
Greil, R.
Zabernigg, A.
Hilbe, W.
Thaler, J.
机构：
[1] St Vincent Hosp Zams, Zams, Austria
[2] Klinikum Kreuzschwestern, Wels, Austria
[3] Med Univ Innsbruck, Innsbruck, Austria
[4] Kufstein Hosp, Kufstein, Austria
[5] Med Univ Klin, Salzburg, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4070
引用
收藏
页码：195S / 195S
页数：1
相关论文
共 50 条
[21]   Prospective results of perioperative chemotherapy (PCT) with cisplatin and irinotecan for locally advanced gastric cancer. [J].
Stelko Pereira, Guilherme Luiz ;
da Fonseca, Leonardo Gomes ;
Kodama Pertille Ramos, Marcus Fernando ;
Ribeiro, Ulysses ;
Pereira, Gabriel ;
Pereira, Marina Alessandra ;
de Mello, Evandro Sobroza ;
Sabbaga, Jorge ;
Hoff, Paulo Marcelo .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[22]   A phase II study of oxaliplatin with ELF regimen in patients with advanced gastric cancer. [J].
Pan, HM ;
Zhu, N ;
Lou, F ;
Guo, Y ;
Jin, W ;
Lou, HZ ;
Zheng, Y .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :364S-364S
[23]   EXIBIT:: An international multicenter phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer. [J].
André, T. ;
Reyes-Vidal, J. M. ;
Fartoux, L. ;
Ross, P. ;
Leslie, M. ;
Rosmorduc, O. ;
Clemens, M. R. ;
Louvet, C. ;
Perez, N. ;
Scheithauer, W. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :211S-211S
[24]   Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer. [J].
Font, A ;
Esteban, E ;
Carles, J ;
Climent, MA ;
Gonzalez-Larriba, JL ;
Berrocal, A ;
Bellmunt, J ;
Garcia-Ribas, I ;
Marfa, X ;
Fabregat, X .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :392S-392S
[25]   Perioperative penpulimab plus anlotinib combined with chemotherapy for locally advanced gastric cancer: A single arm, multicenter, phase II clinical trial. [J].
Wang, Mian ;
Zhou, Wei ;
Miao, Yan ;
Tan, Zhaobang ;
Li, Yiding ;
Hong, Liu .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 :TPS485-TPS485
[26]   Weekly cisplatin/irinotecan and radiotherapy (RT) in patients with locally advanced esophageal cancer : multicenter FFCD phase II trial. [J].
Michel, P ;
Mirabel, X ;
Galais, MP ;
Dahan, L ;
Conroy, T ;
Boucher, E ;
Oprea, C ;
Paillot, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :322S-322S
[27]   A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer [J].
Jeung, Hei-Cheul ;
Rha, Sun Young ;
Noh, Sung Hoon ;
Roh, Jae Kyung ;
Chung, Hyun Cheol .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (03) :313-320
[28]   A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer [J].
Hei-Cheul Jeung ;
Sun Young Rha ;
Sung Hoon Noh ;
Jae Kyung Roh ;
Hyun Cheol Chung .
Cancer Chemotherapy and Pharmacology, 2007, 59 :313-320
[29]   A phase II study of irinotecan, oxaliplatin, 5-fluorouracil, leucovorin (FOLFOXIRI) as a first-line chemotherapy in metastatic gastric cancer. [J].
Lee, J. ;
Kang, W. ;
Lee, S. ;
Kwon, J. ;
Kim, H. ;
Lee, H. ;
Lim, H. ;
Park, J. ;
Park, Y. ;
Park, K. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :197S-197S
[30]   Phase II study of biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer. [J].
Baek, JH ;
Kim, JG ;
Sohn, SK ;
Song, HS ;
Kwon, KY ;
Do, YR ;
Ryu, HM ;
Bae, SH ;
Park, GW ;
Lee, KH .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :325S-325S
12345